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Abstract
While oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2) are
fundamental parameters of brain health and function, a robust MRI-based mapping of OEF and
CMRO2 amenable to functional MRI (fMRI) has not been established. To address this issue, a
novel method called QUantitative Imaging of eXtraction of Oxygen and TIssue Consumption, or
QUIXOTIC, is introduced. The key innovation in QUIXOTIC is the use of velocity-selective spin
labeling to isolate MR signal exclusively from postcapillary venular blood on a voxel-by-voxel
basis. Measuring the T2 of this venular-targeted blood allows calibration to venular oxygen
saturation (Yv) via theoretical and experimental T2 versus blood oxygen saturation relationships.
Yv is converted to OEF, and baseline CMRO2 is subsequently estimated from OEF and additional
cerebral blood flow and hematocrit measurements. Theory behind the QUIXOTIC technique is
presented, and implications of cutoff velocity (VCUTOFF) and outflow time parameters are
discussed. Cortical gray matter values obtained with QUIXOTIC in 10 healthy volunteers are Yv =
0.73 ± 0.02, OEF = 0.26 ± 0.02, and CMRO2 = 125 ± 15 μmol/100 g min. Results are compared to
global measures obtained with the T2 relaxation under spin tagging (TRUST) technique. The
preliminary data presented suggest that QUIXOTIC will be useful for mapping Yv, OEF, and
CMRO2, in both clinical and functional MRI settings.
Keywords
cerebral metabolic rate of oxygen; arterial spin labeling; velocity selective; oxygen extraction
fraction
The rate of oxygen consumption in brain cells is known as the cerebral metabolic rate of
oxygen (CMRO2) and is an important indicator of brain health and function (1). As oxygen
is not produced endogenously in the brain, it must be continuously supplied to meet
metabolic demands. Cerebral blood flow (CBF) fulfills this requirement by delivering
oxygen via hemoglobin, the principal oxygen carrier in the body. The ratio of oxygen
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consumption to oxygen delivery is called the oxygen extraction fraction (OEF). OEF can be
expressed in terms of CMRO2 and CBF (2,3) in the following manner:
[1]
where [Hbtotal] is the total concentration of hemoglobin in blood and Ya is the arterial
oxygen saturation.
One of the main difficulties in measuring OEF and CMRO2 with in vivo 1H MRI is the lack
of a direct contrast mechanism. However, as hemoglobin modulates MR signal relaxivity
based on degree of oxygen saturation (Y), the possibility to indirectly assess OEF and
CMRO2 arises. Venous oxygen saturation (Yv) is extrapolated from the MRI signal and used
first to compute OEF (3):
[2]
where arteriolar blood is assumed fully saturated (Ya = 1) or measured independently by
pulse oximetry. Following Eq. 1, CMRO2 is then calculated from OEF and additional CBF
and hematocrit measurements. As oxygen is typically extracted as blood traverses the
capillary network, Yv measurements focused at the distal end of the network (i.e., in
postcapillary venules) will yield spatially specific OEF and CMRO2 estimates.
One class of methods to measure Yv uses phase contrast imaging to examine magnetic
susceptibility differences between veins and surrounding tissue (4-7) and uses simple, first-
principle models to relate phase changes to Yv. These methods have the advantage of
straightforward acquisitions via standard MRI sequences, but require manually visualizing
vessels, limiting use in measuring regional or voxelwise Yv. A second class of methods (8,9)
invokes an MRI signal model that quantifies Yv based on dHb-induced signal loss in
extravascular tissue. One such approach developed by An et al. uses a single compartment
tissue model to produce OEF (8) and CMRO2 (10) maps. He and Yablonskiy (9) have
introduced “quantitative BOLD” which considers a multiple-compartment model and
accounts for tissue, blood, and cerebrospinal fluid (CSF) signal and similarly produces OEF
maps. This latter approach is especially promising and has been recently used in assessing
change in OEF during functional stimulation (11).
A third class of methods to measure Yv implements an intravascular T2-based approach and
has shown promise in functional MRI (fMRI) settings. This approach uses a theoretically
and empirically derived relationship between blood transverse (T2) relaxation time and
blood oxygen saturation (Y) (2). Specifically measuring Yv requires selective targeting of
blood in the venous circulation, without partial voluming with tissue, CSF, or other brain
constituents. Isolating this pure venous blood signal, however, has been a major challenge
for existing techniques.
As a consequence, intravascular methods require strict selection criteria to identify voxels
containing exclusively venous blood. Methods presented by Oja et al. (3) and Golay et al.
(12), for example, require functional activation experiments to identify candidate voxels,
and of these, only a subset can be used to calculate Yv. Moreover, because of resolution
limitations, usable voxels are typically found only in larger venous vessels. As blood
oxygenation in these larger vessels represents oxygen exchange of all supplying capillaries
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in a large surrounding region, these techniques have fundamental limitations on spatial
specificity. Voxelwise Yv is unfortunately not feasible.
More recently, Lu and Ge have proposed T2 relaxation under spin tagging (TRUST) MRI
and measure Yv in the sagittal sinus (13). TRUST-MRI delivers a pure blood signal, free
from partial volume effects, by using a spin-labeling approach to eliminate static tissue and
CSF via control–tag subtraction. While TRUST is an important advance for T2-based, Yv
methodology, only global estimates are possible, as blood signal is isolated from the largest
cerebral veins (i.e., the sagittal sinus). As such, TRUST Yv measurements are limited to the
terminal draining veins; regional Yv information is consequently lost.
Our work uses the intravascular T2-based approach but addresses the largest obstacle for
localized measurements: the isolation of postcapillary venular (PCV) blood signal. A novel
excitation scheme is proposed that uses velocity-selective spin labeling (VSSL) to isolate
PCV blood signal. In principle, the methodology uses velocity-sensitive pulses to exploit
heterogeneous blood velocities in the vascular tree and subsequently create a flow-
dependent venular blood component that persists after control-tag subtraction. This sequence
incorporates T2 preparation-based technology, acquires PCV blood-weighted images at
effective echo times, and exponentially fits these data to estimate PCV blood T2. T2,blood
versus Y curves (with hematocrit as an independent parameter) are then generated from
theoretical models and existing 3 T data and are used to calibrate PCV blood T2 to Yv. OEF
is then estimated from Yv and combined with CBF (measured with arterial spin labeling
MRI) and hematocrit to quantify CMRO2. This new approach is dubbed QUantitative
Imaging of eXtraction of Oxygen and TIssue Consumption or “QUIXOTIC.”
In this study, we perform QUIXOTIC and TRUST-MRI on 10 healthy subjects and compare
cortical gray matter (GM) values of T2, Yv, OEF, and CMRO2 estimated by QUIXOTIC,
with global values estimated by TRUST. We further present representative Yv, OEF, and
CMRO2 quantitative maps and proceed to explore the dependence of Yv measurements on
key QUIXOTIC parameters.
THEORY
Venular-Targeted Velocity-Selective Spin Labeling
The key innovation behind the QUIXOTIC approach is venular-targeted VSSL (VT-VSSL).
VT-VSSL allows targeting of MR signal exclusively from the PCV blood compartment,
from which T2 and Yv can be measured. VT-VSSL applies velocity-sensitive MR pulses to
exploit differential velocities and accelerations of blood in the vascular tree, and relies on
uniformly forward flow from arteries, through capillaries, to veins. The two-step data
acquisition paradigm creates control and tag images with and without the desired venular
blood component, respectively. Subsequent pairwise control–tag subtraction eliminates
signal from static tissue, CSF, and nonvenular blood compartments, leaving an image
exclusively containing blood in the postcapillary venules. The following section describes
the details and timing behind this approach.
QUIXOTIC is adapted from velocity-selective (VS) arterial spin labeling (14) and uses
similar VS modules to dephase blood spins above a given cutoff velocity. The pulse
sequence is summarized schematically in Fig. 1 and executed for both tag and control
acquisitions.
The principal component of the QUIXOTIC excitation scheme is the VS module. As a time
derivative of position, velocity can be phase encoded by applying bipolar gradient pulses, or
equivalently, unipolar pulses separated by a 180° refocusing pulse (15). Inserting this phase-
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encoding scheme between two excitation pulses with opposite phase (90° − 90°̅) results in
the following radiofrequency (RF) pulse train: 90° − G − 180° − G − 90°̅. When applied to
laminar flow systems found in noncapillary vasculature of the human circulatory system, the
result is a filtering of the magnetization from moving blood spins flowing below a certain
cutoff velocity (VCUTOFF) and elimination of magnetization from spins flowing above
VCUTOFF, according to:
[3]
where M0 is the initial magnetization, v is spin velocity. β is related to the separation (Δ),
duration (δ), and amplitude (G) of the bipolar gradient pulses in the following manner:
[4]
where γ is the gyromagnetic ratio for protons. The first zero-crossing thus defines VCUTOFF
(14,16):
[5]
Figure 2 displays the sinc-filter profile and the ideal velocity filter for comparison.
Instead of using a 90° − G − 180° − G − 90°̅ pulse train, which can be implemented with
simple hard RF pulses, a four RF and four gradient approach was used (as suggested in Ref.
14):
[6]
which incorporates adiabatic pulses as the refocusing 180°s. This train offers greater
resistance to transmitted field (B1+) and static field (B0) inhomogeneity, water diffusion, and
eddy current effects (14,17). Prior investigations using this eight-pulse sequence (14) verify
its superior performance with reduced artifacts compared to data acquired with the simpler
90° − G − 180° − G − 90°̅ train (16). The final VS train is shown in Fig. 3; for perfect spin-
echo refocusing, the adiabatic refocusing pulses are symmetrically spaced.
The difference between the QUIXOTIC tag and control acquisitions lies in the second VS
module. While the tag acquisition applies a user-defined cutoff velocity (VCUTOFF) for both
VS module I (VS1) and VS module II (VS2), the control uses VCUTOFF for VS1, but
disables velocity selection for VS2 (i.e., flowing spins are unaffected, VCUTOFF = infinity).
Incorporated into VS2 is a T2-preparation module (18,19), allowing T2 estimation via data
acquisition at multiple echo times. An important feature of the sequence is an inversion
pulse at TO1, which compensates for adverse effects of T1 relaxation that could potentially
introduce unwanted signal from arterial blood.
To introduce properties of this sequence, we first neglect T1 relaxation and the TO1
inversion pulse. Figure 4 provides an idealized cartoon depicting blood spins in the
circulation for both control and tag acquisitions, their history during the pulse sequence
timing, and the final contribution in the subtracted image. At t = 0, before VS1, all blood
(arterial, venous, capillary) is relaxed (Fig. 4a). Strong velocity weighting (low VCUTOFF) is
then applied during VS1 for both tag and control, selecting for slow moving spins in small
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arterioles, capillaries, and small venules (V < VCUTOFF) but dephasing faster moving spins
in larger vessels (V > VCUTOFF) (resulting in a loss of signal, Fig. 4b). Notably, this large-
vessel signal is eliminated on both sides of the circulation. After VS1, the outflow time (TO)
allows the targeted blood to flow out of the small vessel compartments and accelerate into
larger venular vasculature (Fig. 4c). VS2 is then applied at TO. This time, however, the tag
and control acquisition experience different velocity weighting: the tag sees velocity
selection at VCUTOFF, but the control experiences no velocity weighting. Spins that have
accelerated above VCUTOFF during TO are dephased by the tag acquisition but left unaltered
in the control (Fig. 4d). As imaging starts immediately after VS2, subtraction of tag from
control yields an image weighted to blood that has accelerated from below VCUTOFF to
above VCUTOFF, during TO (Fig. 4e). Assuming flow always progresses from arteries to
capillaries to veins, these spins are venous only. Signal from other sources (static, CSF,
nonvenular blood) is eliminated via subtraction. If VCUTOFF and TO are chosen properly,
signal from PCV blood is exclusively targeted.
Due to the tortuous nature of human vasculature, the spatial direction of flow naturally
varies as blood migrates from arteries to capillaries to veins. This phenomenon, however, is
not expected to appreciably affect the venular selectivity of the VT-VSSL experiment for the
following reasons: first, as phase encoding does not occur during TO (the longest interval of
the experiment), the directional changes during this interval have no impact on velocity
selection. Conversely, directional changes during the VS module will affect selectivity.
However, because the encoding time is so short (approximately 20 ms), directional changes
are both minor and expected to average out given the broad distribution of vessel orientation
in a parenchymal voxel. In this way, as long as there exists some flowing blood with a
velocity component aligned with the encoding direction greater than VCUTOFF, VT-VSSL
can occur. A more detailed discussion of the directional sensitivity of the VS module is
discussed by Frank et al. (20).
T1 relaxation complicates the idealized model depicted in Fig. 4. Spins dephased by VS1 at t
= 0 experience longitudinal magnetization recovery. Because velocity selection via VS2
occurs only for the tag but not control, spins from unwanted compartments will partially
recover in the control, but dephase in the tag at TO+. Without compensation, these unwanted
spins will not subtract completely, and QUIXOTIC loses venous selectivity. To address this
effect, we place an inversion pulse at time TO1 to null recovering blood at TO;
consequently, signal from spins in this unwanted population is eliminated in both control
and tag at TO, leaving only desired PCV blood on subtraction.
To generate the PCV blood-weighted maps at different echo times, T2 preparation is
integrated into the VS2 pulse train. For the shortest effective echo time (TEeff), the VS2
module is exactly as pictured in Fig. 2. For each successive TEeff, an additional pair of
adiabatic 180° pulses is added between the flip-up 90° pulse and first VS gradient lobe. In
this way, the duration of VS2 will increase by ΔTEeff for each successive TEeff. Importantly,
this is done while keeping an identical readout onset time regardless of TEeff. Using T2
preparation and fixing the readout module timing makes the T2 encoding flow insensitive; in
other words, images at successive TEeff should differ only by T2 weighting, not by volume
of blood delivered during TO (18).
Signal intensity (SI) in the acquired blood-weighted images can be plotted versus TEeff and
fit exponentially on a voxel-by-voxel basis to generate T2 maps of PCV blood. T2 values are
then calibrated to Yv and Eqs. 1 and 2 can be used compute CMRO2 and OEF. The
following sections explain these steps in greater detail.
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T2 Estimate: Determination of Effective Echo Times (TEeff)
Proper estimates of T2 from fitting SI versus TEeff data depend on accurate estimates of
TEeff at each successive acquisition. Ideally, TEeff is equal to the duration of the T2-
preparation module, assuming pure T2 relaxation and very short refocusing pulses. In
practice, however, magnetization does not experience pure T2 decay during the hyperbolic
secant refocusing pulses (18), and further, despite a long repetition time (TR; 4 s), a small
amount of residual T1 contamination is present from spins that have not completely relaxed.
To reduce the impact of such biases to the T2 estimate, we derived a small adjustment to the
nominal echo spacing and applied the resulting effective echo spacing, ΔTEeff, for T2
estimation from the measured data. Specifically, we simulated the pulse sequence using the
Bloch equation, assumed T1 and T2 decay during the hyperbolic secant refocusing pulses,
and estimated the ΔTEeff appropriate for our pulse sequence. The T1 and T2 used for the
simulation were 1660 and 70 ms, respectively, which are approximate T1 and T2 values for
deoxygenated blood at 3 T (13,21).
T2,blood Versus Y Calibration
The relationship between transverse relaxation time of blood and blood oxygen saturation
(Y) was first examined in the early 1980s, by Thulborn et al. (22). In years following, a
parametric model based on the Luz–Meiboom model of spin relaxation during two-
compartment exchange (in this case, between plasma and the red blood cell) was derived to
fit experimental data measuring variations of T2,blood and blood oxygen saturation. Such
work enabled MRI-based measurements of oxygen saturation in vivo (23). In 1998, Van Zijl
et al. proposed a fundamental theory for T2-based signal changes in perfused tissue and
presented a quantitative model linking T2 relaxation of blood to physiologic parameters
including Y (2,12). This expression can be written in terms of T2, blood, Y, and hematocrit
(Hct) in the following form:
(7)
where A, B, C, D, and E represent lumped biophysical parameters related to susceptibility
differences between the red blood cell and plasma, water relaxation rates in the red blood
cell and plasma, and the spacing between 180° RF pulses in a CPMG spin-echo module
(τCPMG).
Fit of available Y versus T2,blood data at 3 T obtained from in vitro bovine blood (3 T, Carr
Purcell Meiboom Gill (CPMG) multiecho T2 sequence, τCPMG = 10 ms, courtesy of P. van
Zijl and C. Clingman, Johns Hopkins University), yielded values for A, B, C, D, E, that we
used in our work. Using these values, Y versus T2 curves (with Hct as an independent
parameter) were generated. Bovine blood has the same properties as human blood in terms
of hemoglobin content, erythrocyte size, and diffusional permeability and is expected to
have similar MR relaxation properties (12). It has been successfully used in the past for
similar calibration experiments (12,13,24).
Calculation of CMRO2 From Yv
Once Yv is obtained, CMRO2 and OEF can be calculated by using Eqs. 1 and 2, with the
final hematocrit measurement used to calculate the total hemoglobin concentration:
[8]
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MATERIALS AND METHODS
QUIXOTIC was used to evaluate Yv, OEF, and CMRO2 in healthy volunteers. The protocol
was approved by the University’s Committee of Using Humans as Experimental Subjects.
Ten young (22–32 years) nonsmoking, healthy subjects (six females, four male) were
scanned at 3 T (Siemens Tim Trio, Erlangen, Germany) with the following MRI protocol:
1. T1-weighted magnetization prepared rapid acquisition gradient recalled echo (MP-
RAGE) image for anatomical localization: voxel size = 1 mm3, matrix size = 256 ×
256 × 68, acquisition time = 4 min 32 s.
2. VT-VSSL blood-weighted imaging: VCUTOFF = 2.0 cm/s (G = 1.6 G/cm, Δ = 17
ms, δ = 2 ms, duration between 180 pulses (τ180) = 10 ms, x-directed), TO1 = 400
ms (assuming T1,blood = 1664 ms at 3 T; Ref. 3), TO = 725 ms, τCPMG of T2-
preparation module = 10 ms. A gradient recalled echo planar imaging (EPI) readout
was used for both tag and control image acquisitions: echo time = 12 ms, phase
partial Fourier 6/8, bandwidth = 2232 Hz/pixel, matrix size = 64 × 64, single slice,
voxel size = 3.9 × 3.9 × 10 mm3, TR = 4 s. Eighty measurements were acquired (40
control, 40 tag images), for an imaging time of 5 min 30 s per TEeff. Either five or
six TEeffs (depending on specific absorption rate constraints) were acquired with a
ΔTEeff = 18.4 ms.
3. Pulsed arterial spin label (ASL) CBF imaging: PICORE/Q2tips (25), TI1 = 700 ms,
TI1 stop time = 1400 ms, TI2 = 1600 ms, pulsed ASL gap = 10 mm, Tag thickness
= 160 mm, TR = 2000 ms, one slice, 60 measurements, acquisition time = 2 min.
EPI parameters are as listed for 3). M0 calibration scan had identical imaging
parameters, except ASL-specific pulses were disabled, and only one measurement
was acquired.
4. Double inversion recovery (DIR) for GM-only images: TI1 = 3700 ms, TI2 = 4280
ms, one slice, one measurement, with EPI parameters as listed in 3.
5. TRUST sagittal sinus blood imaging: tag thickness = 50 mm, gap = 10 mm, TI =
800 ms, TR = 8 s, eight measurements per TEeff were acquired, ΔTEeff = 18.0 ms,
one slice. EPI parameters and T2 preparation are as listed for 2. Hyperbolic secant
pulses identical to those in QUIXOTIC were used for TRUST T2 preparation.
Automatic alignment routines (26) were used to ensure similar slice placement among all
subjects. A slightly oblique-axial slice-of-interest was prescribed immediately superior to
the corpus callosum for acquisitions two to four and contained a significant fraction of GM.
A different oblique-axial slice intersecting the sagittal sinus was positioned for acquisition
five (TRUST).
Venular blood-weighted imaging comprised the bulk of the scan session and the imaging
time for the full protocol was less than an hour. Data were acquired at six TEeffs if possible,
but in four subjects, specific absorption rate constraints imposed a limitation of only five
TEeffs. To test the reproducibility, we performed the VT-VSSL experiment twice on two of
the volunteers. These volunteers remained in the scanner for an additional 30 min for the
second VT-VSSL acquisition. The two VT-VSSL trials were spaced approximately half an
hour apart and used identical scan parameters.
After MRI scanning, hematocrit was measured via finger prick blood sample using the
Ultracrit device (Separation Technologies, Altamonte Springs, FL). O2 saturation was
measured with a pulse oximeter (8600FO Pulse Oximeter, Magmedix, Fitchburg, MA).
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The data from each TEeff acquisition were corrected for bulk motion and then subtracted,
control minus tag, in a pairwise fashion. The subtraction series was averaged to produce
mean PCV-weighted images. The DIR image was used as a GM mask, within which venular
blood SI from cortical GM tissue was measured. PCV blood signal intensities from the
entire cortical GM region were plotted versus TEeff to provide whole-slice cortical GM
measurements. The plots were then exponentially fit using a Levenberg–Marquardt least
squares optimization method to measure the T2 relaxation parameter for whole-slice cortical
GM, and the standard error of the estimated parameter (SEE) assuming a t-distribution was
computed.
The TRUST acquisitions were similarly subtracted in a pairwise fraction and averaged to
produce maps containing sagittal-sinus only blood at the five TEeffs. The mean SI from the
six brightest sagittal sinus voxels blood was plotted versus TEeff and fit to estimate sagittal-
sinus blood T2. The SEE assuming a t-distribution was computed.
T2 values from both VT-VSSL and TRUST analyses were then calibrated to Yv using curves
generated with Eq. 7, incorporating the hematocrit measured from the volunteer. As VT-
VSSL data derive mostly from blood in small vessels, the T2 versus Y calibration was
calculated using the microvascular hematocrit (i.e., by multiplying the measured hematocrit
by 0.85 to correct for hematocrit differences between small and large vessels; Ref. 27). This
correction was not needed for the TRUST calibration curves, as the source of venous blood
was exclusively from the large sagittal sinus. Ya was taken as the oxygen saturation
measured with the pulse oximeter; Eq. 2 was then used to calculate OEF.
To obtain CMRO2 from Eq. 1, CBF was estimated by ASL MRI, with a VT-VSSL matching
slice prescription. The ASL data were similarly analyzed to generate blood flow-weighted
images, via subtraction, motion correction, and signal averaging. These images were
calibrated to absolute CBF maps by using the local tissue proton density provided by the M0
scan (28). GM CBF was estimated from the region segmented by the DIR GM mask. White
matter (WM) CBF was estimated from the remaining, nonsegmented brain region. The WM
and GM CBF values were used to calculate whole brain CBF, by assuming a whole-brain
WM:GM ratio of 0.675:1 (29). With these additional CBF measurements, and by using
hematocrit to estimate [Hbtotal], both QUIXOTIC (GM) and TRUST (whole brain) CMRO2
were, respectively, calculated.
To demonstrate feasibility of using QUIXOTIC to create quantitative Yv, OEF, and CMRO2
maps, raw data from a representative subject were smoothed with a 10 mm full width at half
maximum (FWHM) Gaussian kernel and fit for T2, but this time on a voxel-by-voxel basis
(as opposed to using a GM mask). The resultant T2 map was subsequently calibrated to
generate quantitative Yv and OEF maps, using aforementioned calibration curves. Finally a
CMRO2 map was generated by multiplying the OEF map with the absolute ASL-CBF map
on a voxel-by-voxel basis and incorporating [Hbtotal] and Ya (as described in Eq. 1).
Finally, to briefly investigate effects of the two key QUIXOTIC parameters, TO and
VCUTOFF, on the measured Yv, three of the original 10 subjects returned for a separate,
additional imaging session and were scanned at five different TOs (525, 625, 725, 825, and
925 ms) with a fixed VCUTOFF of 2.0 cm/s, and four different VCUTOFFs (1.5, 2.0, 3.0, and
4.0 cm/s) with a fixed TO of 725 ms. As using the standard QUIXOTIC approach to explore
this parameter space would have resulted in impractical scan times (approximately 5 h), a
faster variant (a so-called “turbo QUIXOTIC” approach) was developed and incorporated.
Turbo QUIXOTIC uses a turbo spin echo EPI readout to generate images at multiple echo
times per TR; this contrasts the standard T2 preparation approach, which acquires a single
TEeff image per TR. Turbo QUIXOTIC thus obtains the full set of images for a particular
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TO-VCUTOFF combination in a single scan, allowing data for the above parameter
exploration to be acquired in less than an hour. Specific imaging parameters were: TEeff =
22.6 ms, bandwidth = 3256 Hz/pixel, matrix size = 32 × 32, single slice, voxel size = 7.8 ×
7.8 × 10 mm3, TR = 4 s, generalized autocalibrating partially parallel acquisition with 3×
acceleration. Eighty measurements were acquired at four TEeffs, resulting in 40 control/40
tag per TEeff, and an imaging time of 5 min 30 s per TO/VCUTOFF combination. A
resolution-matched double IR image was acquired for GM segmentation; subsequent data
processing to calculate Yv was performed as described for the standard approach.
Data processing was done in Neurolens (www.neurolens.org) software and with custom
Matlab (MathWorks, Natick, MA) routines.
RESULTS
Figure 5 shows the mean difference images for the VT-VSSL and TRUST acquisitions at
five effective TEs for a representative subject. The signal in the VT-VSSL images is our
estimate of the PCV blood, which decays with a T2 time constant that depends on the blood
oxygenation level.
Figure 6a and b show the ASL-CBF map and the GM mask, respectively. Figure 6c displays
the slice orientation of the preceding acquisitions, overlaid on a high resolution midsagittal
section from the MP-RAGE scan.
Figure 7 shows the whole-slice cortical-GM SI versus TEeff (QUIXOTIC) and sagittal sinus
SI versus TEeff (TRUST) on a semilog scale for all subjects, including the fitted lines for T2
estimates. All line fits had high R2 values: ≥0.95 for QUIXOTIC and ≥0.99 for TRUST. To
improve the figure readability and highlight the relevant parameter (slope of line fits), the
vertical offset of each line in each technique has been normalized. The y-intercept estimates
the volume of tagged blood that remains after subtraction within the sagittal sinus and GM
voxels for TRUST and QUIXOTIC, respectively, but does not enter the OEF or CMRO2
estimates.
Figure 8 shows calibration curves generated with Eq. 7 for the same subject. Values of A, B,
C, D, and E for Eq. 7 were found as 1.09 s−1, 11.26 s−1, −7.96 s−1, 1.08 s−1/2, and 16.54
s−1/2, respectively. Two curves are depicted for both microvascular and macrovascular
hematocrit, to be used for QUIXOTIC and TRUST analyses, respectively. Lower hematocrit
shifts the T2,blood versus Y curve to the left, resulting in lower estimated oxygen saturations
(Y) for a fixed measured T2,blood value.
Figure 9 shows the Yv, OEF, and CMRO2 maps for the same representative subject, created
by applying QUIXOTIC theory on a voxel-by-voxel basis. Yv and OEF is seen to be
relatively uniform across the entire brain, while the CMRO2 map shows substantially higher
values in the GM cortex, compared to the interior WM.
Figure 10a and b show Yv versus TO and Yv versus VCUTOFF, respectively, for the parameter
exploration data acquired with turbo QUIXOTIC in the three reimaged subjects. These data
show the dependence of Yv on these parameters; error bars on the individual data points
represent the SEE (roughly ± 1% for all data points). According to Fig. 9a, Yv is relatively
stable across the chosen range of TO values (mean coefficient of variation across TO trials =
1.8 ± 0.4%), with a very slight decreasing trend (mean slope of linear fits, ΔYv/ΔTO =
−0.007/100 ms). Fig. 9b, however, suggests substantially more variation in Yv across the
VCUTOFF range (mean coefficient of variation across TO trials = 4.2 ± 2.4%); more
importantly, there seems a more pronounced downward trend in Yv as VCUTOFF increases
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(mean slope of linear fits, ΔYv/ΔVCUTOFF = −0.03 s/cm), suggesting dependence of
estimated Yv on the choice of VCUTOFF.
Table 1 summarizes the measured blood relaxation times and the estimated quantitative
physiological parameters for the 10 subjects, i.e., T2, Yv, OEF, CBF, and CMRO2. These
values are shown for QUIXOTIC (regional cortical GM and whole-slice cortical GM) and
TRUST (whole brain). The QUIXOTIC estimates were Yv = 0.73 ± 0.02, OEF = 0.26 ± 0.02
and CMRO2 = 125 ± 15 μmol of O2/(100 g min), while TRUST yielded Yv = 0.63 ± 0.02,
OEF = 0.36 ± 0.02, and CMRO2 = 125 ± 18 μmol of O2/(100 g min).
Table 2 shows the intrascan test–retest data for subjects 1 and 2, including the percent
difference in the quantified parameters. The differences were low in both cases, less than 1%
and 5% for subjects 1 and 2, respectively.
DISCUSSION
We have introduced a novel MR technique, QUIXOTIC, to quantify regional OEF and
regional CMRO2 and have demonstrated its use in normal volunteers. Our estimates of
cortical GM OEF and CMRO2 fall within the expected physiological range and are
comparable with those reported by other MRI and positron emission tomography methods
(10,30-33). Some studies that measure OEF specifically report values of 35%, 42.6%, 41%,
and 40% (34-37), which are slightly higher than the 26% reported here. WM values were not
calculated in this investigation, due to low WM SNR in VT-VSSL maps for several subjects.
QUIXOTIC produces venular blood maps by creating flow-derived signal from within the
imaging voxel. In principle, this property allows generation of venular blood maps on a
voxel-by-voxel basis. By obtaining maps at several effective echo times (Teff), it is possible
to fit for T2 and subsequently obtain voxelwise measures of Yv, OEF, and CMRO2 (as
shown in Fig. 9). Of note, we assumed T1 and T2 values of 1660 and 70 ms, respectively, to
estimate ΔTEeff via Bloch simulation. Deviations in these assumed values will result in a
small bias in the QUIXOTIC measured T2s of venular blood. To examine this effect more
closely, we tested: (a) the range of T1s from 1560 and 1760 and found a resulting effect of
approximately 0.5 ms on estimated T2, and (b) the range of T2s between 50 and 90 ms,
resulting in an effect of approximately 2.5 ms on measured T2. Even at the extremes, these
small deviations in measured T2 will result in even smaller deviations on measured Yv, OEF,
and CMRO2 (between 1 and 2%); well within the noise of our measurement.
Outflow Time and Cutoff Velocity (VCUTOFF)
Two key parameters define the nature of the QUIXOTIC signal and directly control its
spatial specificity, signal-to-noise ratio (SNR), and maximum SNR: cutoff velocity
(VCUTOFF) and TO. When taken together, VCUTOFF and TO determine the extent of the
velocity-selected bolus at imaging time by defining its trailing and leading edge,
respectively, and subsequently the venular blood component remaining in the subtracted
image.
The TO of the QUIXOTIC experiment determines the SNR and spatial specificity of the
subtracted venular blood component. During TO, blood spins accelerate above the VCUTOFF
threshold and into receiving venular vasculature within the imaging voxel. Imaging signal is
created, and intensity increases as these spins begin to fill the imaging voxel. Neglecting T1
decay, the final SI is directly proportional to the volume of blood that has accelerated above
VCUTOFF during TO, while still remaining within the voxel (hereafter termed as “imaging
blood volume”). Realistically, however, T1 decay will have a competing effect on overall SI;
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thus in practice, an SNR-optimized TO will consider both imaging blood volume and T1
decay.
As flowing spins in the velocity-selected bolus disseminate through the tortuous venular
microvasculature during TO, they flow deeper into the venous circulation, and the leading
edge of the bolus travels further away from capillary sites of gas exchange. As long as these
tagged spins do not leave the voxel, oxygen saturation within these pools properly represents
oxygen exchange of their capillary sources. Spatial specificity is preserved, and imaging
blood volume is exactly the product of venular outflow and TO.
VCUTOFF determines the maximum possible SNR of the venular blood component in the
final image, by defining the maximum available vascular volume that can be occupied by
the venular bolus. As blood velocity is closely related to vessel caliber, VCUTOFF not only
defines the cutoff blood velocity, but also determines how far into the venous vascular tree
the trailing edge of imaged bolus is located. A low VCUTOFF means that trailing edge
originates closer to the distal end of the capillary bed, while a high VCUTOFF means that the
trailing edge originates closer to terminal draining veins. As VCUTOFF increases, the trailing
edge moves farther along the venous vascular tree, effectively reducing the remaining
vascular voxel volume that can be filled by tagged blood. In this way, VCUTOFF sets a hard
limit to the maximum imaging blood volume that can occupy a voxel, with lower VCUTOFFs
offering higher SI at the optimal TO. A VCUTOFF just above capillary blood velocities is the
ideal choice. A VCUTOFF lower than capillary velocities is undesirable for three reasons: (1)
VS theory assumes laminar flow, not capillary plug flow (14), for proper velocity filtering,
(2) as VCUTOFF decreases, the relaxed blood pool available to flow above VCUTOFF will at
some point become small, also resulting in SNR reduction, and (3) when large velocity
weighting is applied, tissue and CSF water diffusion becomes a contaminating source of
signal (14). Notably, prior VS-ASL studies have indicated that a VCUTOFF ≥ 2 cm/s will
result in subtractions free from diffusion contamination (14,38).
Based on the above considerations and pilot data (39), we chose VCUTOFF = 2 cm/s and TO
= 725 ms. These choices yield sufficient SNR in the final venular blood images for cortical
analysis at 3 T and maintain high spatial specificity. As seen in Fig. 5, venular blood signal
appears well-matched to cortical gyri, with minimal blurring, which can be appreciated by
comparing the venular blood-weighted images to the CBF and DIR images in Fig. 6.
In this initial demonstration of QUIXOTIC, we performed limited exploration of the
dependence of Yv on TO and VCUTOFF parameters. This required development of the turbo
QUIXOTIC variant, which allowed the considerably shorter scan times needed to
accommodate a multiparameter exploration. Turbo QUIXOTIC differs from the standard
approach by using a turbo spin echo readout to acquire data at multiple effective TEs per
scan, instead of only at a single TEeff. Consequently, turbo QUIXOTIC generates all
necessary images for T2 fitting and subsequent analysis in a single scan, thereby reducing
the required imaging time by several fold. In this specific implementation, the total
acquisition time for a fixed TO and VCUTOFF combination decreased from 25–30 min to 5.5
min. This dramatic reduction in imaging time enabled us to explore several TO and
VCUTOFF combinations in a single scan session. We used this approach in three subjects to
see how calculated Yv varied across (1) a range of TOs at a fixed VCUTOFF = 2 cm/s, and (2)
a range of VCUTOFFs at a fixed TO = 725 ms. Figure 10 shows the calculated Yv across these
parameter ranges. The average slope of −0.007 per 100 ms for the Yv versus TO data (Fig.
10a) suggests that the measured Yv is robust to variations in TO; across a range of 400 ms,
this translates to a less than 3% variation in Yv. On the other hand, Fig. 10b indicates a more
significant dependence of Yv on the VCUTOFF parameter; an average slope of −0.03 per cm/s
suggests that as VCUTOFF increases over a range of 4 cm/s, the measured Yv will decrease by
Bolar et al. Page 11
Magn Reson Med. Author manuscript; available in PMC 2012 December 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
12%. Whether this effect is an artifact of increased diffusion weighting at lower VCUTOFFs,
or a consequence of the physiologic properties of the isolated venular pool that survives
after velocity encoding, is the topic of detailed future QUIXOTIC studies.
An additional positive consequence of using turbo QUIXOTIC is that R2 for all T2 fits was
>0.99, with an SEE of roughly 3 ms; this marks a substantial improvement over the standard
QUIXOTIC variant. We postulate that this improvement is due the fact that turbo
QUIXOTIC is considerably more resistant to both bulk and physiological motion for the
following reasons: (1) motion affects all TEeff points equally in turbo QUIXOTIC due to
parallel TEeff acquisition, whereas it will affect each TEeff point differently in standard
QUIXOTIC (due to serial TEeff acquisition) leading to noiser SI versus TEeff data and (2)
total scan time is significantly shorter in turbo QUIXOTIC, resulting in less motion artifact
across the experiment. Due to higher quality data and reduced scan time, we expect turbo
QUIXOTIC to eventually be the variant of choice for Yv, OEF, and CMRO2 voxel-by-voxel
mapping.
Comparison of QUIXOTIC and TRUST Measurements
Values of OEF and CMRO2 estimated with QUIXOTIC fall within the physiologic range
and are in good agreement with other PET and MR measures in the literature. The key
physiologic parameter measured by QUIXOTIC is local venular oxygen saturation Yv,
which shows low measurement variability across 10 subjects (coefficient of variation =
0.03). Of note, however, is that the whole-slice cortical GM Yv measurements by
QUIXOTIC were significantly higher than sagittal sinus Yv measured with TRUST (0.73 vs.
0.63 for QUIXOTIC and TRUST, statistically different at P < 0.00001, paired t-test).
Moreover, the 95% CI for the true difference in Yv between the techniques lies between 0.08
and 0.11, suggesting a systematic bias between the two techniques. This Yv discrepancy
translates into a lower OEF for QUIXOTIC, compared to TRUST (0.26 vs. 0.36). Table 1
highlights these differences, where whole-brain Yv measured with TRUST is on average
14% less than the single-slice cortical GM Yv measured with QUIXOTIC.
Sources of bias may originate from the QUIXOTIC technique itself. Among these is
contamination of the venular-derived VS bolus by arterial blood, which could manifest in at
least two different ways. As mentioned in Theory section, initially dephased arterial blood
will experience T1 recovery after VS1. In an effort to prevent this blood from giving rise to
signal in the final subtraction, we inserted a single inversion pulse at a time TO1, which in
theory should null this arterial component. TO1 is based on an assumed T1,blood (21); if the
true T1,blood differs significantly from this assumed value, the inversion null may not be
effective, leading to an arterial contribution in the final subtracted signal. As the T2 of fully
oxygenated arterial blood is greater than 150 ms (as empirically determined by ASL-based
experiments using an identical T2-preparation module), a small fractional contribution of
arterial signal could bias the measured T2, and subsequently Yv. To explore this potential
contamination source, we implemented and tested a double-inversion approach in
QUIXOTIC (data not shown), which dramatically improves nulling robustness and reduces
signal across a much wider T1 range (but imposes an additional specific absorption rate
penalty). Comparing the single- and double-inversion variants of QUIXOTIC did not yield a
substantial change in measured T2, leading us to conclude that arterial contamination by
incomplete T1 nulling is not a dominant source of error.
Another possibility for arterial contamination could be attributed to the nonideal velocity
selection profile. While the ideal velocity-selective profile perfectly preserves signal from
all spins below VCUTOFF and dephases all spins above VCUTOFF, the actual VS profile
follows a sinc envelope as a function of spin velocity (Fig. 2). Consequently, the final VS
bolus will also have a sinc-like shape, including side lobes that extend into the arterial side
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of the circulation. As TO increases, the VS bolus will move further into the venous
circulation, and the side lobes on the arterial side become smaller, resulting in less
contamination. This potential contamination source was explored with turbo QUIXOTIC in
three subjects, and as previously mentioned, there was little variation in measured Yv across
a TO range of 400 ms. These turbo QUIXOTIC data suggest that this source of arterial
contamination is not a large source of bias in QUIXOTIC.
A second potential source of bias in measuring Yv with QUIXOTIC is the inevitable
diffusion weighting in the experiment. The combination of gradient and RF pulses that allow
velocity selection will at the same time lead to (mild) diffusion weighting. As the control
image acquisition involves turning off the gradients during VS2, the control image will not
be diffusion weighted, while the tag image will be slightly diffusion weighted. The
subsequent subtraction map will have some degree of diffusion weighting, thus introducing
both tissue and CSF components into the otherwise pure venular blood-weighted images.
This problem was explored by Wong and colleagues for VS-ASL (14,40). Both studies
concluded that diffusion effects were minimal, due to the weak gradients (G), short gradient
durations (δ), and large gradient separation (Δ) used in the VS module. In our specific
experiments, b value was calculated to be approximately 1 s/mm2, leading to less than
0.07% attenuation in tissue (Dtissue = 0.0008 mm2/s) and less than 0.020% attenuation in
CSF (DCSF = 0.0024 mm2/s), given CSF and tissue fractions of up to 95% (41) and up to
10% (42), respectively. Given that the subtracted blood-weighted signal is roughly 2% of the
original signal, we expect less than 4% error from diffusion effects at TEeff = 0. However,
because the T2s of CSF and tissue are longer than the T2 of deoxygenated blood, diffusion-
based effects could become more prominent at longer effective echo times. Results from the
turbo QUIXOTIC parameter exploration are consistent with this idea. As seen in (Fig. 10b).
Yv (and thus T2) increases with decreasing VCUTOFF. One explanation for this phenomenon
is that lower VCUTOFFs result in images containing non-negligible signal from diffusing
tissue/CSF water. As water from these sources has a larger T2 than venular blood water, the
measured T2 (and subsequent Yv) could be biased upward. In this limited turbo QUIXOTIC
dataset, it is also interesting to note that as VCUTOFF increases (and diffusion effects abate),
parenchymal Yv values trend towards global Yv values measured by TRUST. Further studies
are needed to investigate these effects in greater detail.
Finally, a physiological source to the TRUST-QUIXOTIC Yv discrepancy cannot be ruled
out, especially based on the dramatic difference in the location and size of the targeted
vessels in each technique. TRUST measures Yv from the final draining vein of the cerebral
circulation, the sagittal sinus. At this stage of the circulation, oxygen exchange is complete,
and blood is expected to be at its lowest level of oxygenation. In contrast, QUIXOTIC by
design measures oxygenation of blood in venules just distal to draining capillary beds. If
extraction is not complete by the time blood reaches the distal end of the capillaries,
exchange will continue to occur until equilibrium is reached. Such a phenomenon would
result in early venular blood to remain more oxygenated than blood in terminal draining
veins, resulting in QUIXOTIC Yv values greater than TRUST sagittal sinus Yv values. A
more detailed investigation is required to properly determine if such a phenomenon could
exist and play role in the TRUST-QUIXOTIC Yv discrepancy.
An important practical difference between TRUST and QUIXOTIC is SNR. SNR is directly
related to the imaging blood volume, which is represented by the vertical intercepts in Fig.
7a. Because of the high fractional blood volume in the sagittal sinus (approximately 1), the
imaging blood volume is between one and two orders of magnitude greater in TRUST,
compared to QUIXOTIC. In this way, TRUST has a major SNR advantage, affording
shorter imaging times and higher precision fits.
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While beyond the scope of this article, a brief comment can be made on the feasibility of
using QUIXOTIC (and more specifically the turbo QUIXOTIC variant) in functional MRI.
The primary advantage offered by QUIXOTIC is the ability to generate a OEF and CMRO2
map every two TR (analogous to how CBF maps are generated in ASL-fMRI). While the
TR used in these studies was 4 s, shorter TRs (on the order of 2 ms) are possible, with
similar temporal SNR. In this way, similar to functional ASL-MRI, we anticipate useful
application of QUIXOTIC in block design and event-related fMRI experiments. One
potential confounder is the increase of local CBF during activation; however, we do not
anticipate this to cause a large error. While the trailing edge of the VT-VSSL bolus will be
closer to the capillary bed during activation, venular blood will still be considered and
oxygenation properly represented (substantial venular oxygenation heterogeneity, however,
could complicate this picture).
CONCLUSIONS
QUIXOTIC MRI introduces a novel approach to isolate PCV blood signal and subsequently
measure cerebral Yv, OEF, and CMRO2. Values reported for Yv, OEF, and CMRO2 are
comparable with those acquired by other PET and MR studies, and fall within a normal
physiological range. Advantages of QUIXOTIC include: (1) QUIXOTIC maps blood in the
venous circulation only, with CSF, static tissue, and capillary/arterial blood eliminated; (2)
subject to SNR constraints, QUIXOTIC analysis can be performed on a voxel-by-voxel
basis, allowing creation of Yv, OEF, and CMRO2 maps; and (3) QUIXOTIC generates
images every two TR, making the technique amenable to functional imaging of Yv and OEF
during block-design and event-related fMRI. To our knowledge, no currently available
technique offers all three features. Future studies will explore optimal parameter settings,
employ turbo QUIXOTIC for rapid data acquisition, and deploy QUIXOTIC at higher fields
for increased SNR.
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FIG. 1.
QUIXOTIC pulse sequence timing diagram. Sequence is played once for control image
generation and repeated for tag image generation. What differs between control and tag
acquisition is velocity weighting in the VS2/T2-preparation module.
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FIG. 2.
Mz modulation produced by velocity selective pulse; ideal filter (black rect function) and
implemented filter (blue sinc function), given example VCUTOFF of 1 cm/s. [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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FIG. 3.
Velocity selective module: real (blue) and imaginary (red) RF waveforms (top) and gradient
waveform (bottom). Degree of velocity weighting (i.e., the cutoff velocity, VCUTOFF) is
defined by the gradient strength (G), gradient duration (δ), and gradient separation (Δ).
Disabling velocity selectivity implies G = 0. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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FIG. 4.
Idealized cartoon of venular blood signal targeting in QUIXOTIC approach, as told via spin
configuration throughout the experiment. Relaxed spins are denoted by upright arrows;
dephased spins by hollow circles. Dotted vertical lines correspond to 1 cm/s blood velocity
(i.e., the cutoff velocity in b and d).
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FIG. 5.
TRUST (top) and QUIXOTIC (bottom) mean difference images from representative subject.
Mean difference images are an average of many control–tag subtractions and reflect sagittal-
sinus blood weighting in TRUST and venular blood weighting in QUIXOTIC.
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FIG. 6.
Representative CBF image (top-left), DIR image (bottom-left), and anatomical MP-RAGE
with prescribed slice overlay (right). QUIXOTIC, ASL, and DIR sequences acquired data in
this slice orientation.
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FIG. 7.
TRUST and QUIXOTIC log(SI) versus effective echo time curves and corresponding T2 fits
for all 10 subjects. Vertical offset of the fit lines have been normalized for minimum
variance within TRUST and QUIXOTIC datasets. Solid blue and red lines represent mean
T2 fit curves for all 10 subjects, for TRUST and QUIXOTIC, respectively. The vertical
intercept estimates the imaging blood volume within sagittal sinus and GM voxels for
TRUST and QUIXOTIC, respectively. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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FIG. 8.
Representative T2 versus Y calibration curves for the representative subject, generated with
microvascular (red) and macrovascular (blue) hematocrit, using Eq. 7. These curves are used
to calibrate T2 to blood oxygen saturation for the QUIXOTIC and TRUST experiments.
[Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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FIG. 9.
Quantitative Yv (left), OEF (middle), and CMRO2 (right) maps for representative subject,
created by applying QUIXOTIC theory on a voxel-by-voxel basis.
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FIG. 10.
Yv versus TO (a) and Yv versus VCUTOFF (b) for the parameter exploration data acquired
with turbo QUIXOTIC in three reimaged subjects. Error bars represent the SEE.
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